Does Lymphadenectomy Improve Survival in Uterine Leiomyosarcoma?

Tasci T., Karalok A., TAŞKIN S., Ureyen I., Kimyon G., Tulek F., ...Daha Fazla

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, cilt.25, sa.6, ss.1031-1036, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 6
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1097/igc.0000000000000452
  • Dergi Adı: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1031-1036
  • Anahtar Kelimeler: Uterine leiomyosarcoma, Lymph node dissection, Prognosis, ENDOMETRIAL STROMAL SARCOMA, GYNECOLOGIC-ONCOLOGY-GROUP, SMOOTH-MUSCLE TUMORS, PROGNOSTIC-FACTORS, LYMPH-NODE, STAGE-I, ADJUVANT CHEMOTHERAPY, UTERUS, VALIDATION, METASTASES
  • Ankara Üniversitesi Adresli: Evet

Özet

Introduction The role of lymphadenectomy in the management of uterine leiomyosarcoma (LMS) is controversial. We aimed to identify whether lymph node dissection (LND) has any survival benefit in uterine LMS.